Breast Cancer
ASCO and CAP Announce New HER-2 Testing GuidelinesASCO and CAP Announce New HER-2 Testing Guidelines
Published in Women's Health Weekly, March 8th, 2007
Clarient, Inc. (Nasdaq: CLRT), a technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the Company's existing HER-2 testing practices meet or exceed new HER-2 testing guidelines recently formulated by the American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) and published in the January issues of the Journal of Clinical Oncology and the Archives of Pathology and Laboratory and Medicine.
HER-2 (human epidermal growth factor receptor 2) testing is used to select the breast cancer patients that are most likely to respond to Herceptin(R), the first humanized antibody...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Alzheimer Disease
'Give It to Me Straight, Doc:' New National Survey Reveals People Want to Know Now What Diseases Await Them in Their Future... Even If There's No Cure - Arthritis
Stryker Sponsors Speaking of Women's Health to Bring Osteoarthritis Education to Millions of Women Nationwide - Biomedical Engineering
American Journal of Obstetrics & Gynecology Relaunched to Better Serve the Needs of the Busy Physician - Biomedical Engineering
Cytyc to Acquire Adeza Biomedical Corporation - Breast Cancer
ASCO and CAP Announce New HER-2 Testing Guidelines - Breast Cancer
Celera Presents Data Validating Its Metastasis Score as a Molecular Prognostic Tool in Breast Cancer - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
